Table 3.
Factors associated with severe Kikuchi-Fujimoto disease using logistic regression model.
| Variables | Univariate | Multivariable | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Age | 0.956 (0.910–1.004) | 0.073 | ||
| Sex | 0.768 | |||
| Female | Reference | |||
| Male | 1.282 (0.246–6.688) | |||
| Systemic symptoms | ||||
| Fever duration | 1.212 (0.941–1.560) | 0.137 | ||
| Myalgia | 0.150 (0.024–0.946) | 0.044 | 0.035 (0.001–0.792) | 0.035 |
| Laboratory findings | ||||
| CRP (≥ 100 mg/L) | 0.632 (0.092–4.350) | 0.641 | ||
| LDH (≥ 1000 IU/L) | 1.944 (0.192–19.741) | 0.574 | ||
| PET-CT parameters | ||||
| Total lymph nodes SUVmax (> 9.27) | 8.500 (1.335–54.127) | 0.023 | 24.734 (1.323–462.407) | 0.032 |
| Total lymph nodes MTV (> 34.72) | 6.667 (1.057–42.065) | 0.044 | ||
| Total lymph nodes TLG (> 429.99) | 10.889 (1.140–103.977) | 0.038 | ||
| Spleen SUVmean (> 1.79) | 11.111 (1.701–72.564) | 0.012 | 37.770 (1.769–806.583) | 0.020 |
| Spleen TLG (> 296.06) | 10.500 (1.412–78.059) | 0.022 | ||
| Relapse | 1.050 (0.093–11.824) | 0.968 | ||
| Steroid use | 0.762 (0.122–4.751) | 0.771 | ||
OR, Odds ratio; CI, confidential interval; SUVmax, maximum standardized uptake value; SUVmean, mean standardized uptake value; MTV, metabolic tumor volume; TLG, total lesion glycolysis; CRP, C-reactive protein; LDH, lactate dehydrogenase